GDNSF · Goodness Growth Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.20M | - | $91.66M | $48.06M | $24.54M | - | $25.17M | $25.11M | $24.09M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | $59.30M | - | $37.38M | $20.42M | $12.41M | - | $12.32M | $13.55M | $12.24M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $30.80M | - | $29.68M | $12.45M | $7.47M | - | $6.91M | $7.56M | $7.05M | - |
| Total Operating Expenses | $50.30M | - | $36.57M | $22.44M | $10.44M | - | $8.47M | $7.76M | $7.48M | - |
| D&A | $4.00M | - | $552.6K | $387.6K | $622.4K | - | $76.3K | $72.9K | $633.7K | - |
| Operating Income | $9.00M | - | $809.0K | ($2.02M) | $1.98M | - | $3.85M | $5.79M | $4.76M | - |
| Interest Expense | - | - | $6.91M | $7.65M | $8.72M | - | $7.92M | $7.74M | $8.72M | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($20.30M) | - | ($26.30M) | ($14.93M) | ($6.51M) | - | ($4.93M) | ($668.4K) | ($6.71M) | - |
| EPS - Basic | ($0.02) | - | ($0.03) | ($0.03) | ($0.02) | - | ($0.02) | $0.00 | ($0.05) | - |
| EPS - Diluted | ($0.02) | - | ($0.03) | ($0.03) | ($0.02) | - | ($0.02) | $0.00 | ($0.05) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $137.80M | $122.49M | $117.54M | $106.19M | $86.26M | $91.60M | $7.28M | $11.23M | $12.60M | $15.96M |
| Accounts Receivable | $14.10M | $12.67M | $11.19M | $9.14M | $2.42M | $2.87M | $2.85M | $2.26M | $2.75M | $3.09M |
| Inventory | $76.10M | $59.97M | $53.90M | $63.03M | $23.34M | $21.67M | $19.85M | $20.09M | $19.36M | $19.29M |
| Accounts Payable | $20.70M | $18.87M | $14.91M | $14.20M | $6.46M | $2.30M | $3.76M | $3.79M | $2.11M | $1.77M |
| Current Assets | $258.30M | $305.11M | $307.96M | $312.79M | $228.43M | $230.37M | $143.96M | $148.63M | $147.18M | $148.85M |
| Total Assets | $928.80M | $817.15M | $678.92M | $659.34M | $277.05M | $278.86M | $193.87M | $194.68M | $190.88M | $183.26M |
| Current Liabilities | $215.80M | $191.53M | $234.91M | $243.52M | $137.66M | $135.47M | $128.77M | $186.77M | $184.24M | $179.47M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $634.70M | $509.73M | $432.61M | $390.76M | $226.61M | $223.30M | $204.87M | $217.24M | $213.46M | $199.31M |
| Stockholders' Equity | $294.10M | $307.42M | $246.31M | $268.58M | $50.44M | $55.56M | ($11.00M) | ($22.56M) | ($22.58M) | ($16.04M) |
| Retained Earnings | ($319.90M) | ($299.55M) | ($279.18M) | ($252.88M) | ($237.94M) | ($231.44M) | ($215.73M) | ($210.81M) | ($210.14M) | ($203.43M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.90M | - | - | - | ($3.32M) | - | - | - | ($1.19M) | - |
| Investing Cash Flow | $8.00M | - | - | - | ($1.15M) | - | - | - | ($1.05M) | - |
| Financing Cash Flow | ($4.60M) | - | - | - | ($874.4K) | - | - | - | ($1.12M) | - |
| CapEx | $10.80M | - | - | - | $1.15M | - | - | - | $899.3K | - |
| Free Cash Flow | $1.10M | - | - | - | ($4.47M) | - | - | - | ($2.09M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 55.8% | - | 40.8% | 42.5% | 50.6% | - | 49.0% | 54.0% | 50.8% | - |
| Operating margin | 8.5% | - | 0.9% | -4.2% | 8.1% | - | 15.3% | 23.1% | 19.8% | - |
| EBITDA margin | 12.2% | - | 1.5% | -3.4% | 10.6% | - | 15.6% | 23.4% | 22.4% | - |
| Net margin | -19.1% | - | -28.7% | -31.1% | -26.5% | - | -19.6% | -2.7% | -27.9% | - |
| Free cash flow margin | 1.0% | - | - | - | -18.2% | - | - | - | -8.7% | - |
| FCF / Net income | -0.05 | - | - | - | 0.69 | - | - | - | 0.31 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 29.0% | - | 32.4% | 25.9% | 30.5% | - | 27.5% | 30.1% | 29.3% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -2.2% | - | -3.9% | -2.3% | -2.3% | - | -2.5% | -0.3% | -3.5% | - |
| Return on equity | -6.9% | - | -10.7% | -5.6% | -12.9% | - | 44.8% | 3.0% | 29.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.20 | 1.59 | 1.31 | 1.28 | 1.66 | 1.70 | 1.12 | 0.80 | 0.80 | 0.83 |
| Quick ratio | 0.84 | 1.28 | 1.08 | 1.03 | 1.49 | 1.54 | 0.96 | 0.69 | 0.69 | 0.72 |
| Cash ratio | 0.64 | 0.64 | 0.50 | 0.44 | 0.63 | 0.68 | 0.06 | 0.06 | 0.07 | 0.09 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | 0.1x | -0.3x | 0.2x | - | 0.5x | 0.7x | 0.5x | - |
| Equity multiplier | 3.16 | 2.66 | 2.76 | 2.45 | 5.49 | 5.02 | -17.62 | -8.63 | -8.46 | -11.42 |
| Liabilities / Assets | 0.68 | 0.62 | 0.64 | 0.59 | 0.82 | 0.80 | 1.06 | 1.12 | 1.12 | 1.09 |
| Efficiency | ||||||||||
| Asset turnover | 0.11 | - | 0.14 | 0.07 | 0.09 | - | 0.13 | 0.13 | 0.13 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 48d | - | 45d | 69d | 36d | - | 41d | 33d | 42d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 1.4x | - | 2.5x | 0.9x | 3.3x | - | - | - | - | - |
| P / S | 3.9x | - | 6.6x | 4.9x | 6.9x | - | 3.8x | 2.6x | 2.4x | - |
| EV / EBITDA | 21.0x | - | 360.1x | - | 31.7x | - | 22.4x | 9.4x | 8.6x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 332.8% | - | 264.2% | 91.4% | 1.9% | - | 2.0% | 24.3% | 26.2% | - |
| Revenue CAGR (3y) | 77.2% | - | 69.4% | 31.6% | 16.2% | - | 23.5% | 20.8% | 25.7% | - |
| Revenue CAGR (5y) | 54.4% | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 377.8% | - | 203.3% | 50.7% | 1.4% | - | -6.6% | 45.2% | 28.6% | - |
| Operating income growth (YoY) | 355.5% | - | -79.0% | - | -58.5% | - | -34.4% | - | 1191.6% | - |
| Net income growth (YoY) | -211.9% | - | -433.8% | -2134.3% | 3.0% | - | 5.8% | 90.9% | 20.2% | - |
| EPS growth (YoY) | 0.0% | - | -50.0% | - | 60.0% | - | 50.0% | - | 28.6% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | -113.9% | - | - | - | 47.7% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 483.1% | 453.3% | - | - | - | - | 14.4% | -184.7% | -991.8% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$268.77M totalRetail$219.93M · 81.8%
Wholesale Product$48.84M · 18.2%
Peer comparison
Same SIC group: Pharmaceutical Preparations
Comparing Goodness Growth Holdings against the 5 most active filers in the same SIC group.